Education
About Us
Working with TipRanks
Follow Us
CK Life Sciences International (Holdings), Inc. (HK:0775)
:0775
Total Valuation
CK Life Sciences International (Holdings), Inc. has a market cap or net worth of HK$9.90B. The enterprise value is HK$13.87B.
Market CapHK$9.90B
Enterprise ValueHK$13.87B
Share Statistics
CK Life Sciences International (Holdings), Inc. has 9,611,072,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,611,072,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CK Life Sciences International (Holdings), Inc.’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 11.02%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)11.02%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee2.72M
Profits Per Employee-62.25K
Employee Count2,033
Asset Turnover0.51
Inventory Turnover3.31
Valuation Ratios
The current PE Ratio of CK Life Sciences International (Holdings), Inc. is ―. CK Life Sciences International (Holdings), Inc.’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.71
PB Ratio1.12
Price to Fair Value1.12
Price to FCF25.58
Price to Operating Cash Flow64.12
PEG Ratio0.04
Income Statement
In the last 12 months, CK Life Sciences International (Holdings), Inc. had revenue of 5.52B and earned -126.55M in profits. Earnings per share was -0.01.
Revenue5.52B
Gross Profit1.69B
Operating Income783.06M
Pretax Income-91.48M
Net Income-126.55M
EBITDA337.27M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 202.07M and capital expenditures -196.53M, giving a free cash flow of 5.54M billion.
Operating Cash Flow202.07M
Free Cash Flow5.54M
Free Cash Flow per Share<0.01
Dividends & Yields
CK Life Sciences International (Holdings), Inc. pays an annual dividend of HK$0.008, resulting in a dividend yield of ―
Dividend Per ShareHK$0.008
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.80
52-Week Price Change92.16%
50-Day Moving Average0.95
200-Day Moving Average0.74
Relative Strength Index (RSI)55.25
Average Volume (3m)5.82M
Important Dates
CK Life Sciences International (Holdings), Inc. upcoming earnings date is Mar 24, 2026, TBA (Confirmed).
Last Earnings DateAug 12, 2025
Next Earnings DateMar 24, 2026
Ex-Dividend DateMay 23, 2023
Financial Position
CK Life Sciences International (Holdings), Inc. as a current ratio of 1.28, with Debt / Equity ratio of 173.70%
Current Ratio1.28
Quick Ratio0.78
Debt to Market Cap1.39
Net Debt to EBITDA16.44
Interest Coverage Ratio2.32
Taxes
In the past 12 months, CK Life Sciences International (Holdings), Inc. has paid 35.07M in taxes.
Income Tax35.07M
Effective Tax Rate-0.38
Enterprise Valuation
CK Life Sciences International (Holdings), Inc. EV to EBITDA ratio is 28.13, with an EV/FCF ratio of 61.57.
EV to Sales1.72
EV to EBITDA28.13
EV to Free Cash Flow61.57
EV to Operating Cash Flow26.83
Balance Sheet
CK Life Sciences International (Holdings), Inc. has HK$797.84M in cash and marketable securities with HK$6.50B in debt, giving a net cash position of -HK$5.70B billion.
Cash & Marketable SecuritiesHK$797.84M
Total DebtHK$6.50B
Net Cash-HK$5.70B
Net Cash Per Share-HK$0.59
Tangible Book Value Per Share<HK$0.01
Margins
Gross margin is 30.65%, with operating margin of 14.18%, and net profit margin of -2.29%.
Gross Margin30.65%
Operating Margin14.18%
Pretax Margin-1.66%
Net Profit Margin-2.29%
EBITDA Margin6.11%
EBIT Margin4.45%
Analyst Forecast
The average price target for CK Life Sciences International (Holdings), Inc. is HK$1.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$1.00
Price Target Upside2.04% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast2.10%
EPS Growth Forecast-1350.00%